ZERBI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 14.005
AS - Asia 8.026
EU - Europa 2.632
SA - Sud America 1.277
AF - Africa 357
Continente sconosciuto - Info sul continente non disponibili 270
OC - Oceania 22
Totale 26.589
Nazione #
US - Stati Uniti d'America 13.721
SG - Singapore 5.056
CN - Cina 1.284
BR - Brasile 1.041
VN - Vietnam 826
IT - Italia 598
FI - Finlandia 433
IE - Irlanda 360
DE - Germania 293
NG - Nigeria 237
HK - Hong Kong 225
FR - Francia 211
GB - Regno Unito 178
CA - Canada 164
IN - India 134
NL - Olanda 127
SE - Svezia 112
AR - Argentina 90
TR - Turchia 85
BD - Bangladesh 80
MX - Messico 65
IQ - Iraq 48
RU - Federazione Russa 44
PL - Polonia 42
ZA - Sudafrica 42
BE - Belgio 39
ES - Italia 38
JP - Giappone 36
IL - Israele 33
CO - Colombia 31
UA - Ucraina 31
EC - Ecuador 28
CL - Cile 26
VE - Venezuela 26
ID - Indonesia 23
PK - Pakistan 21
SA - Arabia Saudita 21
MA - Marocco 20
AU - Australia 19
AT - Austria 18
JM - Giamaica 18
MY - Malesia 17
AE - Emirati Arabi Uniti 16
CH - Svizzera 16
PH - Filippine 14
EG - Egitto 13
RO - Romania 13
UZ - Uzbekistan 13
PY - Paraguay 12
LT - Lituania 11
NP - Nepal 11
AZ - Azerbaigian 10
UY - Uruguay 10
ET - Etiopia 9
GR - Grecia 9
IR - Iran 9
KZ - Kazakistan 9
CZ - Repubblica Ceca 8
HN - Honduras 8
TN - Tunisia 8
BO - Bolivia 7
DZ - Algeria 7
JO - Giordania 7
BG - Bulgaria 6
DO - Repubblica Dominicana 6
OM - Oman 6
PE - Perù 6
RS - Serbia 6
AL - Albania 5
CR - Costa Rica 5
DK - Danimarca 5
GE - Georgia 5
HU - Ungheria 5
KR - Corea 5
TT - Trinidad e Tobago 5
CI - Costa d'Avorio 4
KE - Kenya 4
KG - Kirghizistan 4
LB - Libano 4
NO - Norvegia 4
SN - Senegal 4
TH - Thailandia 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CW - ???statistics.table.value.countryCode.CW??? 3
EU - Europa 3
HR - Croazia 3
KH - Cambogia 3
LV - Lettonia 3
MD - Moldavia 3
MT - Malta 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
BB - Barbados 2
BH - Bahrain 2
CG - Congo 2
CY - Cipro 2
EE - Estonia 2
GA - Gabon 2
GH - Ghana 2
Totale 26.302
Città #
Singapore 2.314
Wilmington 1.615
Chandler 1.510
Dallas 1.105
Ashburn 968
The Dalles 719
San Jose 718
Shanghai 617
San Mateo 582
Ann Arbor 482
Council Bluffs 432
Helsinki 424
Dublin 359
Leawood 308
Beijing 299
Boardman 291
New York 281
Princeton 279
Lawrence 275
Ho Chi Minh City 274
Benin City 235
Milan 228
Hong Kong 206
Hanoi 201
Santa Clara 174
Paris 157
Woodbridge 156
Los Angeles 145
Fairfield 132
Amsterdam 108
São Paulo 92
London 80
Rome 78
Phoenix 77
Seattle 77
Toronto 76
Buffalo 64
San Diego 53
Munich 49
Orem 44
Kocaeli 39
Da Nang 36
Norwalk 36
Rio de Janeiro 36
Chicago 35
Brooklyn 34
Warsaw 34
Brussels 33
Falkenstein 33
Haiphong 33
Atlanta 32
Chennai 28
Brasília 25
Montreal 25
Abbiategrasso 24
Assago 24
Boston 24
Hải Dương 24
Tokyo 24
Charlotte 23
Johannesburg 23
Mexico City 23
Frankfurt am Main 21
Houston 21
Milwaukee 21
Washington 20
Curitiba 19
Monmouth Junction 19
Stockholm 19
Belo Horizonte 18
Dhaka 18
Philadelphia 18
San Francisco 18
Baghdad 17
Denver 17
Mumbai 17
Naples 17
Manchester 16
Springfield 16
Biên Hòa 14
Bologna 14
Campinas 14
Columbus 14
Figino 14
Fort Worth 14
Guarulhos 14
Porto Alegre 14
Pune 14
Redmond 14
Redwood City 14
Miami 13
Tashkent 13
Fortaleza 12
Kingston 12
Sacramento 12
Hillsboro 11
Newark 11
Salvador 11
Bogotá 10
Des Moines 10
Totale 17.513
Nome #
CLINICAL PRESENTATION OF BONE METASTASES IN NEUROENDOCRINE TUMORS: A RETROSPECTIVE COHORT STUDY 380
Prognostic Factors and Survival Outcomes in Resected Biliary Tract Cancers: A Multicenter Retrospective Analysis 314
Serum CA 19-9 in the postsurgical follow-up of patients with pancreatic cancer 141
A Bone in the Pancreas 134
A Rare Case of Cushing Syndrome Caused by an Ectopic ACTH-Secreting Pancreatic Neuroendocrine Tumor in a Patient with Von Hipple-Lindau Disease 133
Can SBRT improve the prognosis of unresectable pancreatic cancer? Clinical results on 106 patients 119
Pancreatic surgery outcomes: multicentre prospective snapshot study in 67 countries 116
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 116
Determination of CA 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis. 112
A multicenter survey on distal pancreatectomy in Italy: results of minimally invasive technique and variability of perioperative pathways. 111
The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma 110
"PancPro" as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases 107
Commentary to paper "Primary versus secondary delayed gastric emptying (DGE) grades B and C of the International Study Group of Pancreatic Surgery after pancreatoduodenectomy: a retrospective analysis on a group of 132 patients". 107
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study 105
A Snapshot of Elective Oncological Surgery in Italy During COVID-19 Emergency: Pearls, Pitfalls, and Perspectives 105
Assessment of Perioperative Body Composition at Bioimpedance Vector Analysis (BIVA) Predicts Morbidity Following Pancreatic Resection for Cancer 104
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study 104
Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS) 103
[Advances and perspectives in acute pancreatitis]. FT Novita e prospettive nella pancreatite acuta. 103
A Partnership Model Between High- and Low-Volume Hospitals to Improve Results in Hepatobiliary Pancreatic Surgery 102
Enhanced Recovery After Pancreatic Surgery Does One Size Really Fit All? A Clinical Score to Predict the Failure of an Enhanced Recovery Protocol After Pancreaticoduodenectomy 102
Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma 101
A cost-benefit analysis of surgical approach to pancreatic cancer 101
An uncommon cause of massive intraperitoneal bleeding: leiomyoblastoma of the stomach. 99
A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile 99
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 99
Pancreatic serous cystoadenoma (CSA) showing increased tracer uptake at 68-GaDOTA-peptide Positron Emission Tomography (68Ga-DOTA-peptide PET-CT): a case report 99
INTRAOPERATIVE RADIATION-THERAPY ADJUVANT TO RESECTION IN THE TREATMENT OF PANCREATIC-CANCER 98
Application of minimally invasive pancreatic surgery: an Italian survey 98
[Biliary cystadenoma. Description of 2 clinical cases]. FT Il cistoadenoma biliare. Descrizione di due casi clinici. 97
Postoperative management of patients with total exocrine pancreatic insufficiency 97
Long-term outcomes after pancreatoduodenectomy for ampullary cancer: The influence of the histological subtypes and comparison with the other periampullary neoplasms 97
BEYOND PALLIATION: USING EUS-GUIDED CHOLEDOCHODUODENOSTOMY WITH A LUMEN-APPOSING METAL STENT AS A BRIDGE TO SURGERY 96
A prospective multicentre survey on the treatment of acute pancreatitis in Italy 96
A randomized phase II trial of two different four-drug combinations in advanced pancreatic adenocarcinoma: Cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel 96
A novel insight into the anticancer mechanism of metformin in pancreatic neuroendocrine tumor cells 96
Diagnostic assessment and outcome of acute pancreatitis in Italy: Results of a prospective multicentre study - ProInf-AISP: Progetto informatizzato pancreatite acuta, Associazione Italiana Studio Pancreas, phase II 95
Prognostic value of the immune-related transcriptome in biliary tract cancers 94
Characterisation of the immune-related transcriptome in resected biliary tract cancers 94
FOXA2 controls the cis-regulatory networks of pancreatic cancer cells in a differentiation grade-specific manner 94
Perspectives from Italy during the COVID-19 pandemic: nationwide survey-based focus on minimally invasive HPB surgery 93
What role does hand-assistance have in minimally invasive pancreatic surgery? 92
Dissection of transcriptional and cis-regulatory control of differentiation in human pancreatic cancer 92
Alteration of the immunophenotype and cytokine profiles in patients affected by neuroendocrine neoplasms 91
Immune infiltrating cells in duodenal cancers 91
Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers 90
Ampullary neuroendocrine neoplasms: surgical experience of a rare and challenging entity 90
Value of abdominal sonography and MR imaging at 0.5 T in preoperative detection of pancreatic insulinoma: A comparison with dynamic CT and angiography 90
SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience. 90
The evolution of post-operative pancreatic fistula (POPF) classification: A single-center experience 89
Management and Outcomes of Pancreatic Resections Performed in High-Volume Referral and Low-Volume Community Hospitals Lead by Surgeons Who Shared the Same Mentor: The Importance of Training 89
Effect of hospital volume on outcome of pancreaticoduodenectomy in Italy 89
DIABETES AND THE RISK OF PANCREATIC-CANCER 89
[Computerized tomography versus nuclear magnetic resonance in acute pancreatitis]. FT Tomografia computerizzata versus risonanza magnetica nucleare nella pancreatite acuta. 88
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study 87
CA 19.9, CA 242 and CEA in the diagnosis and follow-up of pancreatic cancer 87
Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy 87
Consequences of Increases in Antibiotic Resistance Pattern on Outcome of Pancreatic Resection for Cancer 87
[Treatment of the pancreatic stump after cephalic pancreatoduodenectomy]. FT Il trattamento del moncone pancreatico dopo duodenocefalopancreatectomia. 87
Clinicopathological Correlates of Hormone Expression-Based Subtypes of Non-Functioning Duodenal/Ampullary Neuroendocrine Tumors: A Multicenter Study of 151 Cases 86
[Personal experience in surgical resection of pancreatic carcinoma]. FT Esperienza personale nella chirurgia resettiva del carcinoma pancreatico. 86
Diagnosis and treatment of acute pancreatitis: The position statement of the Italian Association for the study of the pancreas 86
[Intraoperative radiotherapy as adjuvant treatment for resection of carcinoma of the pancreas]. FT La radioterapia intraopertoria come trattamento adiuvante alla resezione nel carcinoma del pancreas. 86
A machine learning risk model based on preoperative computed tomography scan to predict postoperative outcomes after pancreatoduodenectomy 85
Pancreatoduodenectomy with occlusion of the residual stump by Neoprene injection. 85
Pancreatic Neuroendocrine Tumours: The Role of Endoscopic Ultrasound Biopsy in Diagnosis and Grading Based on the WHO 2017 Classification 85
Intraoperative ultrasound with contrast medium in resective pancreatic surgery: a pilot study 84
Carbohydrate Antigen 19-9 Change During Chemotherapy for Advanced Pancreatic Adenocarcinoma 84
Adjuvant therapy is associated with improved overall survival in patients with pancreatobiliary or mixed subtype ampullary cancer after pancreatoduodenectomy - A multicenter cohort study 84
A randomized clinical trial to compare the efficacy of continuous local anesthetic wound infusion with thoracic epidural analgesia in post-operative pain control after pancreatic surgery 83
The Five Periampullary Cancers, not Just Different Siblings but Different Families: An International Multicenter Cohort Study 82
Role of C-Reactive Protein Assessment as Early Predictor of Surgical Site Infections Development after Pancreaticoduodenectomy 82
The borderline resectable/locally advanced pancreatic ductal adenocarcinoma: What should be the surgeon's choice? 82
Ultrasonic dissection versus conventional dissection techniques in pancreatic surgery: a randomized multicentre study 82
Parenchyma-sparing surgery for pancreatic endocrine tumors. 82
A POSTGRADUATE TEACHING COURSE IN LAPAROSCOPIC SURGERY 82
Antitumorigenic and antiinsulinogenic effects of calcitriol on insulinoma cells and solid beta-cell tumors 81
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study. 81
Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study 81
Pancreatic enzyme replacement therapy in post-pancreatectomy patients. 80
Efficacy of an absorbable fibrin sealant patch (TachoSil) after distal pancreatectomy: a multicenter, randomized, controoled trial 80
Final results of a prospective trial of a PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen followed by radiotherapy after curative surgery for pancreatic adenocarcinoma 80
Fat-absorptiom and gastroenteric pH profile in postsurgical pancreatic insufficiency: Role of the association of H2-receptor antagonists with pancreatic enzymes 80
Effect of Surgeon Volume on Outcome Following Pancreaticoduodenectomy in a High-Volume Hospital 80
Safety and efficacy of preoperative or postoperative chemotherapy for resectable pancreatic adenocarcinoma (PACT-15): a randomised, open-label, phase 2-3 trial 80
Irrelevance of microsatellite instability in the epidemiology of sporadic pancreatic ductal adenocarcinoma 80
Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma 80
Independent effect of fat-to-muscle mass ratio at bioimpedance analysis on long-term survival in patients receiving surgery for pancreatic cancer 79
REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer 79
RELIABILITY OF PANCREATIC-CANCER STAGING CLASSIFICATIONS 79
The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: Regulation of expression and potential mechanisms of antimalignant activity 79
The Number of Metastatic Lymph Nodes is a Useful Predictive Factor for Recurrence after Surgery for Nonmetastatic Nonfunctional Neuroendocrine Neoplasm of the Pancreas 79
CT-guided pancreatic percutaneous fine-needle biopsy in differential diagnosis between pancreatic cancer and chronic pancreatitis. 79
Arterial vs pancreatic phase: which is the best choice in the evaluation of pancreatic endocrine tumourswith multidetector computed tomography (MDCT)? 79
Ampullary Neuroendocrine Neoplasms: Identification of Prognostic Factors in a Multicentric Series of 119 Cases 78
Pancreatic metastases: An increasing clinical entity. 78
Morphohistological Features of Pancreatic Stump Are the Main Determinant of Pancreatic Fistula after Pancreatoduodenectomy 78
Pylorus-preserving pancreaticoduodenectomy versus conventional whipple operation 78
Preparazione del paziente e vie d'accesso 78
Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis 78
Totale 9.702
Categoria #
all - tutte 174.795
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 174.795


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.287 0 0 52 334 15 12 45 217 134 112 280 86
2022/20234.071 613 164 383 442 388 346 7 311 753 357 269 38
2023/20242.179 169 210 464 90 37 211 111 197 53 33 185 419
2024/20253.846 71 191 132 38 39 415 211 344 554 903 422 526
2025/202610.682 1.482 666 1.054 974 285 429 3.085 577 519 634 389 588
2026/20271.493 590 885 18 0 0 0 0 0 0 0 0 0
Totale 26.589